S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
Log in
NASDAQ:AKTS

Akoustis Technologies Stock Forecast, Price & News

$7.90
+0.06 (+0.77 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.80
Now: $7.90▼
$8.00
50-Day Range
$7.48
MA: $8.08▼
$8.54
52-Week Range
$3.76
Now: $7.90▼
$9.55
Volume282,216 shs
Average Volume575,007 shs
Market Capitalization$302.24 million
P/E RatioN/A
Dividend YieldN/A
Beta1.57
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industries in the United States. The company operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and smart systems technology and commercialization center foundry, as well as manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, and Wi-Fi premise equipment. The company was founded in 2014 and is headquartered in Huntersville, North Carolina.
Read More
Akoustis Technologies logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.50 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Telephone & telegraph apparatus
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:AKTS
Previous Symbol
CUSIPN/A
CIK1584754
Webwww.akoustis.com
Phone704-997-5735
Employees69

Debt

Debt-to-Equity Ratio0.56
Current Ratio7.54
Quick Ratio7.52

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.79 million
Price / Sales168.85
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.14 per share
Price / Book6.93

Profitability

EPS (Most Recent Fiscal Year)($0.86)
Net Income$-36,140,000.00
Net Margins-2,018.99%
Return on Equity-81.49%
Return on Assets-47.51%

Miscellaneous

Outstanding Shares38,258,000
Market Cap$302.24 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$7.90
+0.06 (+0.77 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for AKTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

How has Akoustis Technologies' stock been impacted by Coronavirus (COVID-19)?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AKTS stock has increased by 48.8% and is now trading at $7.90.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Akoustis Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Akoustis Technologies.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Akoustis Technologies.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies Inc (NASDAQ:AKTS) announced its quarterly earnings results on Monday, August, 24th. The technology company reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of ($0.25) by $0.02. The technology company had revenue of $0.37 million for the quarter, compared to analysts' expectations of $0.43 million. Akoustis Technologies had a negative return on equity of 81.49% and a negative net margin of 2,018.99%.
View Akoustis Technologies' earnings history.

What price target have analysts set for AKTS?

4 brokerages have issued 12 month price targets for Akoustis Technologies' stock. Their forecasts range from $7.00 to $12.00. On average, they anticipate Akoustis Technologies' share price to reach $10.00 in the next year. This suggests a possible upside of 26.6% from the stock's current price.
View analysts' price targets for Akoustis Technologies.

Who are some of Akoustis Technologies' key competitors?

Some companies that are related to Akoustis Technologies include NETGEAR (NTGR), AudioCodes (AUDC), Telkom SA Ltd ADS (TLKGY), Plantronics (PLT), ADTRAN (ADTN), Clearfield (CLFD), DASAN Zhone Solutions (DZSI), Franklin Wireless (FKWL), Zoom Telephonics (ZMTP), Sunworks (SUNW), AltiGen Communications (ATGN), Sonim Technologies (SONM), Communications Systems (JCS), Clearone (CLRO) and Westell Technologies (WSTL).
View all competitors.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology Group (MRVL), Alibaba Group (BABA), InVitae (NVTA), Advanced Micro Devices (AMD), Crispr Therapeutics (CRSP) and JD.com (JD).

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:
  • Mr. Jeffrey B. Shealy, Founder,Pres, CEO & Director (Age 50)
  • Mr. David M. Aichele, VP of Bus. Devel. (Age 53)
  • Mr. Kenneth Boller, Interim Chief Financial Officer
  • Mr. Thomas Andrew Sepenzis, Director of Investor Relations (Age 47)
  • Mr. Drew Wright, Gen. Counsel & Corp. Sec.

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mission Wealth Management LP (0.64%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies.

Which major investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Mission Wealth Management LP. Company insiders that have sold Akoustis Technologies company stock in the last year include David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, and Steven Denbaars.
View insider buying and selling activity for Akoustis Technologies.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $7.90.

How big of a company is Akoustis Technologies?

Akoustis Technologies has a market capitalization of $302.24 million and generates $1.79 million in revenue each year. The technology company earns $-36,140,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis. Akoustis Technologies employs 69 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]

This page was last updated on 10/20/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.